CVRx Future Growth
Future criteria checks 1/6
CVRx is forecast to grow earnings and revenue by 5.7% and 11.6% per annum respectively while EPS is expected to grow by 8.5% per annum.
Key information
5.7%
Earnings growth rate
8.47%
EPS growth rate
Medical Equipment earnings growth | 12.8% |
Revenue growth rate | 11.6% |
Future return on equity | n/a |
Analyst coverage | Good |
Last updated | 09 May 2025 |
Recent future growth updates
Recent updates
Investors Appear Satisfied With CVRx, Inc.'s (NASDAQ:CVRX) Prospects As Shares Rocket 25%
May 09CVRx, Inc.: Overreaction Creates Buying Opportunity
Apr 09Expanding 48 US Territories And New Codes Will Broaden Access
Mar 29 Expansion in US territories and implanting centers is expected to drive significant revenue growth and market penetration.With A 29% Price Drop For CVRx, Inc. (NASDAQ:CVRX) You'll Still Get What You Pay For
Mar 07Revenues Tell The Story For CVRx, Inc. (NASDAQ:CVRX) As Its Stock Soars 27%
Jan 16Does CVRx (NASDAQ:CVRX) Have A Healthy Balance Sheet?
Dec 26CVRx: Impressive Top-Line Growth Seems Priced In
Nov 07Analyst Estimates: Here's What Brokers Think Of CVRx, Inc. (NASDAQ:CVRX) After Its Third-Quarter Report
Nov 01Investors Still Waiting For A Pull Back In CVRx, Inc. (NASDAQ:CVRX)
Oct 10Does CVRx (NASDAQ:CVRX) Have A Healthy Balance Sheet?
Jul 31Why Investors Shouldn't Be Surprised By CVRx, Inc.'s (NASDAQ:CVRX) 32% Share Price Surge
Jun 18The Price Is Right For CVRx, Inc. (NASDAQ:CVRX) Even After Diving 47%
May 04Rock star Growth Puts CVRx (NASDAQ:CVRX) In A Position To Use Debt
Apr 10The Price Is Right For CVRx, Inc. (NASDAQ:CVRX) Even After Diving 25%
Feb 29Revenues Tell The Story For CVRx, Inc. (NASDAQ:CVRX) As Its Stock Soars 34%
Nov 11Companies Like CVRx (NASDAQ:CVRX) Are In A Position To Invest In Growth
Aug 20CVRx Pursues Revenue Growth But Operating Losses Worsen
Aug 05Earnings and Revenue Growth Forecasts
Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
---|---|---|---|---|---|
12/31/2027 | 68 | -46 | -42 | -53 | 2 |
12/31/2026 | 68 | -48 | -37 | -39 | 6 |
12/31/2025 | 56 | -52 | -35 | -35 | 4 |
3/31/2025 | 53 | -52 | -42 | -41 | N/A |
12/31/2024 | 51 | -60 | -41 | -39 | N/A |
9/30/2024 | 47 | -58 | -40 | -39 | N/A |
6/30/2024 | 44 | -54 | -38 | -37 | N/A |
3/31/2024 | 42 | -52 | -41 | -40 | N/A |
12/31/2023 | 39 | -41 | -40 | -39 | N/A |
9/30/2023 | 35 | -43 | -43 | -42 | N/A |
6/30/2023 | 31 | -43 | -46 | -45 | N/A |
3/31/2023 | 26 | -43 | -43 | -42 | N/A |
12/31/2022 | 22 | -41 | -43 | -43 | N/A |
9/30/2022 | 19 | -41 | -40 | -39 | N/A |
6/30/2022 | 16 | -38 | -38 | -37 | N/A |
3/31/2022 | 14 | -44 | -35 | -33 | N/A |
12/31/2021 | 13 | -43 | -29 | -28 | N/A |
9/30/2021 | 11 | -36 | -26 | -25 | N/A |
6/30/2021 | 9 | -33 | -21 | -21 | N/A |
3/31/2021 | 7 | -19 | -17 | -17 | N/A |
12/31/2020 | 6 | -14 | -16 | -16 | N/A |
12/31/2019 | 6 | -15 | -13 | -13 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: CVRX is forecast to remain unprofitable over the next 3 years.
Earnings vs Market: CVRX is forecast to remain unprofitable over the next 3 years.
High Growth Earnings: CVRX is forecast to remain unprofitable over the next 3 years.
Revenue vs Market: CVRX's revenue (11.6% per year) is forecast to grow faster than the US market (8.4% per year).
High Growth Revenue: CVRX's revenue (11.6% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if CVRX's Return on Equity is forecast to be high in 3 years time
Discover growth companies
Company Analysis and Financial Data Status
Data | Last Updated (UTC time) |
---|---|
Company Analysis | 2025/05/12 15:08 |
End of Day Share Price | 2025/05/09 00:00 |
Earnings | 2025/03/31 |
Annual Earnings | 2024/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
Package | Data | Timeframe | Example US Source * |
---|---|---|---|
Company Financials | 10 years |
| |
Analyst Consensus Estimates | +3 years |
|
|
Market Prices | 30 years |
| |
Ownership | 10 years |
| |
Management | 10 years |
| |
Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
CVRx, Inc. is covered by 8 analysts. 7 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
Analyst | Institution |
---|---|
William Plovanic | Canaccord Genuity |
Ross Osborn | Cantor Fitzgerald & Co. |
Chase Knickerbocker | Craig-Hallum Capital Group LLC |